Daewoong sales up to 2Q this year rose 13.95%

Published: 2005-10-25 07:00:00

Updated: 2005-10-25 07:00:00

Daewoong disclosed the business performance during 2Q (July to Sept) on Oct. 20 as 79.2 billion won of sales, 16.03% up from the same period of last year but 1.29% down compared to the previous quarter, and for the first 6 months as 159,441 million won of sales, 13.95% up from the same period of...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK